Delivery Order SPE2DB24D1205-SPE2DB24FCTZV

Award Date 8/22/24
Potential Completion Date 9/13/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRODELVY 180 MG VIALS. The contract has a firm fixed price of $9,584.58 and a completion date of May 12, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TRODELVY 180 MG VIALS. The contract has a ceiling value of $6,007.00 and a period of performance ending on September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these specialized pharmaceutical products to support military treatment facilities and other federal healthcare programs. This delivery order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,584.58, is for the delivery of 4,567,873,999 units of the medication TRODELVY 180 MG VIALS. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,429.28, is for the delivery of Trodelvy 180 mg vials, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 12, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,010.50 to Amerisourcebergen Drug Corp, the prime contractor, to provide 180 mg vials of the pharmaceutical drug TRODELVY. The contract has a completion date of March 7, 2024 and was awarded on February 14, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a pharmaceutical product, with a ceiling value of $12,779.44 and a final completion date of February 13, 2025. This is a Firm Fixed Price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a specialty medication, with a ceiling value of $19,169.16 and a period of performance through April 16, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of...
This federal contract award, valued at $9,584.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRODELVY 180 MG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRODELVY 180 MG VIALS. The contract, valued at $18,643.92, is a firm fixed-price delivery order with a completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,974.30 firm fixed-price contract provides for the delivery of 180 mg vials of the drug TRODELVY. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTZV
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trodelvy 180 mg vials. The contract has a ceiling value of $6,007 and a completion date of September 13, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/21/24, 9:40 AM